

Author: Hatala Robert
Publisher: Adis International
ISSN: 1173-2563
Source: Clinical Drug Investigation, Vol.32, Iss.9, 2012-09, pp. : 603-612
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content


American Journal of Cardiovascular Drugs, Vol. 9, Iss. 3, 2009-05 ,pp. :








Amlodipine/Valsartan: Fixed-Dose Combination in Hypertension
By Plosker Greg L. Robinson Dean M.
Drugs, Vol. 68, Iss. 3, 2008-01 ,pp. :